Following Beijing’s announcement on the three-child policy, Chinese child and baby product manufacturers have seen profits rise on the stock market for the second day in a row. Dairy company Beingmate’s shares rose ten percent in Shenzhen, while fertility clinic service provider Jinfa Labi Maternity & Baby Articles saw similar gains, Bloomberg reported. Hubei Goto Biopharm, a maker of pharmaceutical steroid hormones, rose six percent, while the shares of baby and children’s equipment retailer Shanghai Aiyingshi jumped ten percent.
Continue reading now
… and get free access to this Professional Briefing for a month.
Are you already a guest at the China.Table? Log in now